Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure

This publication has 26 references indexed in Scilit:

• Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?
  American Heart Journal, 1998
• Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.
  Journal of the American College of Cardiology, 1997
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
  The Lancet, 1997
• Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
  Circulation, 1996
• Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
  Journal of the American College of Cardiology, 1995
• Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease
  Circulation, 1995
• Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction
  JAMA, 1993
• Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
  Journal of the American College of Cardiology, 1993
• Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
  New England Journal of Medicine, 1993
• Two-, six-, and 12-minute walking tests in respiratory disease.
  BMJ, 1982